Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA complete response letter

Showing 2 posts of 2 posts found.

Arena’s obesity treatment lorcaserin rejected by FDA

October 25, 2010
Sales and Marketing Arena Pharma, Eisai, FDA, FDA complete response letter, lorcaserin, obesity

A new weight loss drug has been rejected by the FDA because of numerous concerns about side-effects and limited efficacy. …

News

FDA rejects Viropharma’s Cinryze manufacturing expansion

October 25, 2010
Sales and Marketing Cinryze, FDA, FDA complete response letter, Viropharma, angioedema, pharmaceutical manufacturing

ViroPharma was dealt a blow late last week when the FDA turned down its application for additional manufacturing capacity for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025